Cellectar Biosciences Profit Margin 2006-2018 | CLRB
Current and historical gross margin, operating margin and net profit margin for Cellectar Biosciences (CLRB) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cellectar Biosciences net profit margin as of September 30, 2018 is 0%.
|Cellectar Biosciences Annual Profit Margins
|Cellectar Biosciences Quarterly Profit Margins
||Medical Products Manufacturing
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.